Is HER2 Evaluation with the CellSearch System a Method Reliable for Detecting HER2 Overexpression?

被引：0
|
作者：
Sandri, M. T. [1 ]
Zorzino, L. [1 ]
Cassatella, M. C. [1 ]
Dell'Orto, P. [1 ]
Stufano, V. [1 ]
Munzone, E. [1 ]
Casadio, C. [1 ]
机构：
[1] European Inst Oncol, Milan, Italy
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-02-13
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Towards comprehensive characterization of HER2 overexpression
    Berezov, Alan
    Greene, Mark I.
    MOLECULAR SYSTEMS BIOLOGY, 2006, 2 (1)
  • [22] Inconsistency of HER2 Status Between Core Needle Biopsy and Surgical Specimens: Focus on HER2 Null, HER2 Ultralow, and HER2 Low
    Wu, Si
    Liu, Hongbo
    Liu, Yueping
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [23] FISH technology in detecting HER2 amplification
    Bartlett, JMS
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 8 - 10
  • [24] SERUM HER2 EXTRACELLULAR DOMAIN LEVELS AND TISSUE HER2 OVEREXPRESSION IN ADVANCED GASTRIC CANCER PATIENTS
    Takahashi, Y.
    Ohori, H.
    Takahashi, M.
    Gamoh, M.
    ANNALS OF ONCOLOGY, 2013, 24 : 32 - 32
  • [25] Reassessment of HER2 status in HER2 negative or HER2 unknown breast cancer patients with recurrent metastatic disease by analyzing serum HER2 and HER2 status of circulating tumor cells.
    Fehm, T.
    Lane, N.
    Solomayer, E.
    Wallwiener, D.
    Uhr, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [26] Correlation between serum HER2 extracellular domain (HER2 ECD) levels and tumour size in early, advanced and metastatic breast cancer with HER2 overexpression
    Makino, H.
    Tengan, H.
    Tatsuda, K.
    Hashidate, H.
    Mio, K.
    Kiguchi, T.
    Yamazaki, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S114 - S115
  • [27] Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy
    Yoshida, Hiroshi
    Nishikawa, Tadaaki
    Matsumoto, Koji
    Mori, Masahiko
    Hirashima, Yasuyuki
    Takehara, Kazuhiro
    Ariyoshi, Kazuya
    Hasegawa, Kosei
    Yonemori, Kan
    VIRCHOWS ARCHIV, 2021, 478 (06) : 1161 - 1171
  • [28] Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy
    Hiroshi Yoshida
    Tadaaki Nishikawa
    Koji Matsumoto
    Masahiko Mori
    Yasuyuki Hirashima
    Kazuhiro Takehara
    Kazuya Ariyoshi
    Kosei Hasegawa
    Kan Yonemori
    Virchows Archiv, 2021, 478 : 1161 - 1171
  • [29] Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers.
    Li, Bob T.
    Zheng, Tao
    Ni, Ai
    Hellmann, Matthew David
    Jordan, Emmet
    Barron, David
    Smyth, Lillian Mary
    Solit, David B.
    Zehir, Ahmet
    Ross, Dara S.
    Berger, Michael F.
    Ladanyi, Marc
    Rudin, Charles M.
    Kris, Mark G.
    Arcila, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Evaluation of HER2 IHC Staining Using the Ventana Image Analysis System, Correlation with HER2 FISH Amplification
    Dennis, J. A.
    Parsa, R.
    Chau, D.
    Peng, Y.
    Sahoo, S.
    Fang, Y. V.
    Sarode, V. R.
    MODERN PATHOLOGY, 2013, 26 : 36A - 36A
12345